Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Rader (2015)
Lysosomal Acid Lipase Deficiency--A New Therapy for a Genetic Lipid Disease.The New England journal of medicine, 373 11
J. Arterburn, W. Lee, R. Wood, B. Shaw, R. Markin (1991)
Orthotopic liver transplantation for cholesteryl ester storage disease.Journal of clinical gastroenterology, 13 4
P. Stenson, M. Mort, E. Ball, K. Howells, A. Phillips, N. Thomas, D. Cooper (2009)
The Human Gene Mutation Database: 2008 updateGenome Medicine, 1
N. Stitziel, S. Fouchier, B. Sjouke, G. Peloso, Alessa Moscoso, P. Auer, A. Goel, B. Gigante, T. Barnes, O. Melander, M. Orho-Melander, S. Duga, S. Sivapalaratnam, M. Nikpay, N. Martinelli, D. Girelli, R. Jackson, C. Kooperberg, L. Lange, D. Ardissino, R. McPherson, M. Farrall, H. Watkins, M. Reilly, D. Rader, U. Faire, H. Schunkert, J. Erdmann, N. Samani, L. Charnas, D. Altshuler, S. Gabriel, J. Kastelein, J. Defesche, A. Nederveen, S. Kathiresan, G. Hovingh (2013)
Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 33
Allen Crocker, Gordon Vawter, Edward Neuhauser, Andre Rosowsky (1965)
WOLMAN'S DISEASE: THREE NEW PATIENTS WITH A RECENTLY DESCRIBED LIPIDOSIS.Pediatrics, 35
M. Veerkamp, J. Graaf, S. Bredie, J. Hendriks, P. Demacker, A. Stalenhoef (2002)
Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families: Results of a 5-Year Follow-Up StudyArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 22
H. Sloan, D. Fredrickson (1972)
Enzyme deficiency in cholesteryl ester storage idisease.The Journal of clinical investigation, 51 7
L. Leone, P. Ippoliti, R. Antonicelli, F. Balli, B. Gridelli (1995)
Treatment and liver transplantation for cholesterol ester storage disease.The Journal of pediatrics, 127 3
D. Fredrickson (1963)
Newly Recognized Disorders of Cholesterol Metabolism.Annals of Internal Medicine, 58
K. Figura, A. Hasilik (1986)
Lysosomal enzymes and their receptors.Annual review of biochemistry, 55
C. Aslanidis, Stefan Ries, P. Fehringer, C. Büchler, H. Klima, G. Schmitz (1996)
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.Genomics, 33 1
D. Ameis, G. Brockmann, R. Knoblich, M. Merkel, R. Ostlund, J. Yang, P. Coates, J. Cortner, S. Feinman, H. Greten (1995)
A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease.Journal of lipid research, 36 2
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 62 16
Ž. Reiner (2013)
Statins in the primary prevention of cardiovascular diseaseNature Reviews Cardiology, 10
Ž. Reiner, O. Guardamagna, D. Nair, H. Soran, K. Hovingh, S. Bertolini, Simon Jones, M. Ćorić, S. Calandra, John Hamilton, Terence Eagleton, E. Ros (2014)
Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.Atherosclerosis, 235 1
B. Burton, P. Deegan, G. Enns, O. Guardamagna, S. Horslen, G. Hovingh, S. Lobritto, V. Malinová, V. McLin, J. Raiman, M. Rocco, S. Santra, Reena Sharma, J. Sykut-Cegielska, C. Whitley, S. Eckert, V. Valayannopoulos, A. Quinn (2015)
Clinical Features of Lysosomal Acid Lipase DeficiencyJournal of Pediatric Gastroenterology and Nutrition, 61
M. Mukherjee (2003)
Human digestive and metabolic lipases—a brief reviewJournal of Molecular Catalysis B-enzymatic, 22
J. Fulcher, R. O'Connell, M. Voysey, J. Emberson, L. Blackwell, B. Mihaylova, J. Simes, R. Collins, A. Kirby, H. Colhoun, E. Braunwald, J. Rosa, T. Pedersen, A. Tonkin, Barry Davis, P. Sleight, M. Franzosi, C. Baigent, A. Keech (2015)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trialsThe Lancet, 385
F. Pagani, R. Pariyarath, Rodolfo Garcia, C. Stuani, A. Burlina, G. Ruotolo, M. Rabusin, F. Baralle (1998)
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.Journal of lipid research, 39 7
M. Elleder, J. Ledvinová, P. Cieslar, R. Kuhn (1990)
Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthoodVirchows Archiv A, 416
M. Brown, S. Dana, J. Goldstein (1975)
Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein.Proceedings of the National Academy of Sciences of the United States of America, 72 8
M. Friedman, V. Valayannopoulos, C. Grande, Alejandra Sánchez, J. Kane, M. Kostyleva, A. Tylki-Szymańska, E. Sokal, Reena Sharma, Sandra Rojas-Caro, Nina Wolfendale, B. Burton (2016)
Safety findings from 3 trials of treatment with sebelipase alfa in children and adults with lysosomal acid lipase deficiencyMolecular Genetics and Metabolism, 117
S. Fouchier, J. Defesche (2013)
Lysosomal acid lipase A and the hypercholesterolaemic phenotypeCurrent Opinion in Lipidology, 24
H. Du, S. Schiavi, M. Levine, J. Mishra, M. Heur, G. Grabowski (2001)
Enzyme therapy for lysosomal acid lipase deficiency in the mouse.Human molecular genetics, 10 16
Peter Jones, A. Goldberg, J. Guyton, Ralph Laforge, J. Mckenney (2016)
National Lipid Association Annual Summary of Clinical Lipidology 2016.Journal of clinical lipidology, 10 1 Suppl
G. Ferry, H. Whisennand, M. Finegold, E. Alpert, A. Glombicki (1991)
Liver transplantation for cholesteryl ester storage disease.Journal of pediatric gastroenterology and nutrition, 12 3
Stefan Ries, C. Aslanidis, P. Fehringer, J. Carel, D. Gendrel, G. Schmitz (1996)
A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.Journal of lipid research, 37 8
A. Abramov, S. Schorr, M. Wolman (1956)
Generalized xanthomatosis with calcified adrenals.A.M.A. journal of diseases of children, 91 3
P. Lohse, S. Maas, P. Lohse, M. Elleder, J. Kirk, G. Besley, D. Seidel (2000)
Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease.Journal of lipid research, 41 1
D. Pratt, M. Kaplan (2000)
Evaluation of abnormal liver-enzyme results in asymptomatic patients.The New England journal of medicine, 342 17
C. Gasche, C. Aslanidis, R. Kain, M. Exner, T. Helbich, C. Dejaco, G. Schmitz, P. Ferenci (1997)
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin.Journal of hepatology, 27 4
G. Koch, P. Lalley, Marcia McAvoy, T. Shows (1981)
Assignment ofLIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19Somatic Cell Genetics, 7
R. Levy, R. Ostlund, G. Schonfeld, Paul Wong, C. Semenkovich (1992)
Cholesteryl ester storage disease: complex molecular effects of chronic lovastatin therapy.Journal of lipid research, 33 7
L. Leone, P. Ippoliti, R. Antonicelli (1991)
Use of simvastatin plus cholestyramine in the treatment of lysosomal acid lipase deficiency.The Journal of pediatrics, 119 6
L. Pisciotta, R. Fresa, A. Bellocchio, E. Pino, V. Guido, A. Cantafora, M. Rocco, S. Calandra, S. Bertolini (2009)
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene.Molecular genetics and metabolism, 97 2
(2008)
Plasma PCSK9 preferentially reduces liver LDL receptors in mice
H. Klima, K. Ullrich, C. Aslanidis, P. Fehringer, K. Lackner, G. Schmitz (1993)
A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.The Journal of clinical investigation, 92 6
J. Horton, Jonathan Cohen, H. Hobbs (2009)
PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008.Journal of Lipid Research, 50
Z Reiner, O Guardamagna, D Nair, H Soran, K Hovingh, S Bertolini, S Jones, M Coric, S Calandra, J Hamilton, T Eagleton, E Ros (2014)
Lysosomal acid lipase deficiency- an under-recognized cause of dyslipidemia and liver dysfunctionArterioscler, 235
J. Tolar, A. Petryk, K. Khan, K. Bjoraker, J. Jessurun, M. Dolan, Teresa Kivisto, L. Charnas, E. Shapiro, P. Orchard (2009)
Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman diseaseBone Marrow Transplantation, 43
J. Schaub, Gritta Janka, H. Christomanou, K. Sandhoff, W. Permanetter, G. Hübner, Peter Meister (1980)
Wolman's disease: Clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcificationEuropean Journal of Pediatrics, 135
S. Muntoni, H. Wiebusch, M. Jansen-Rust, S. Rust, U. Seedorf, H. Schulte, K. Berger, H. Funke, G. Assmann (2007)
Prevalence of cholesteryl ester storage disease.Arteriosclerosis, thrombosis, and vascular biology, 27 8
A. Bisceglie, K. Ishak, L. Rabin, J. Hoeg (1990)
Cholesteryl ester storage disease: Hepatopathology and effects of therapy with lovastatinHepatology, 11
A. Soutar, R. Naoumova (2007)
Mechanisms of Disease: genetic causes of familial hypercholesterolemiaNature Clinical Practice Cardiovascular Medicine, 4
M. Balwani, C. Breen, Gregory Enns, Patrick Deegan, T. Honzík, Simon Jones, John Kane, V. Malinová, Reena Sharma, E. Stock, V. Valayannopoulos, J. Wraith, J. Burg, S. Eckert, E. Schneider, Anthony Quinn (2013)
Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients With cholesteryl ester storage diseaseHepatology, 58
A. Randel (2008)
AHA Guidelines on Cardiac CT for Assessing Coronary Artery DiseaseAmerican Family Physician, 77
W. Marshall, B. Ockenden, A. Fosbrooke, J. Cumings (1969)
Wolman's disease. A rare lipidosis with adrenal calcification.Archives of Disease in Childhood, 44
F. Rassoul, V. Richter, P. Lohse, A. Naumann, K. Purschwitz, E. Keller (2001)
Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease.International journal of clinical pharmacology and therapeutics, 39 5
A. Klein, A. Futerman (2013)
Lysosomal storage disorders: old diseases, present and future challenges.Pediatric endocrinology reviews : PER, 11 Suppl 1
B. Nordestgaard, M. Chapman, S. Humphries, H. Ginsberg, L. Masana, O. Descamps, O. Wiklund, R. Hegele, F. Raal, J. Defesche, A. Wiegman, R. Santos, G. Watts, K. Parhofer, G. Hovingh, P. Kovanen, C. Boileau, M. Averna, J. Borén, E. Bruckert, A. Catapano, J. Kuivenhoven, P. Pajukanta, K. Ray, A. Stalenhoef, E. Stroes, M. Taskinen, A. Tybjærg‐Hansen (2013)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart diseaseEuropean Heart Journal, 34
J. Stein, Ben Garty, Y. Dror, E. Fenig, M. Zeigler, I. Yaniv (2007)
Successful treatment of Wolman disease by unrelated umbilical cord blood transplantationEuropean Journal of Pediatrics, 166
C. Aslanidis, H. Klima, K. Lackner, G. Schmitz (1994)
Genomic organization of the human lysosomal acid lipase gene (LIPA).Genomics, 20 2
P. Cagle, G. Ferry, A. Beaudet, E. Hawkins (1986)
Pulmonary hypertension in an 18-year-old girl with cholesteryl ester storage disease (CESD)American journal of medical genetics, 24 4
J. Goldstein, S. Dana, J. Faust, Arthur Beaudet, Michael Brown (1975)
Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease.The Journal of biological chemistry, 250 21
H. Hulkova, M. Elleder (2012)
Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimensHistopathology, 60
K. Bowden, Nicolas Bilbey, Leanne Bilawchuk, E. Boadu, Rohini Sidhu, D. Ory, H. Du, Teddy Chan, G. Francis (2011)
Lysosomal Acid Lipase Deficiency Impairs Regulation of ABCA1 Gene and Formation of High Density Lipoproteins in Cholesteryl Ester Storage Disease*The Journal of Biological Chemistry, 286
D. Ameis, H. Greten (1996)
Lysosomal acid lipase: a pivotal enzyme in the pathogenesis of cholesteryl ester storage disease and Wolman disease.Zeitschrift fur Gastroenterologie, 34 Suppl 3
(2008)
PCSK9 function and physiology
F Rassoul, V Richter, P Lohse, A Naumann, K Purschwitz, E Keller (2001)
Long-term administration of the HMG CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage diseaseJ Clin Pharmacol Therap, 39
J Hamilton, J Jones, R Srivastava, P Galloway (2012)
A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2Clin Chem Acta, 413
H. Du, S. Schiavi, Nick Wan, M. Levine, D. Witte, G. Grabowski (2004)
Reduction of Atherosclerotic Plaques by Lysosomal Acid Lipase SupplementationArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 24
Simon Jones, A. Brassier, J. Hughes, D. Plantaz, R. Vara, C. Breen, J. Gargus, V. Valayannopoulos (2016)
Effect of sebelipase alfa on survival and liver function in infants with rapidly progressive lysosomal acid lipase deficiency: 2-year follow-up dataMolecular Genetics and Metabolism, 117
W. Krivit, C. Peters, K. Dusenbery, Y. Ben-yoseph, N. Ramsay, J Wagner, R. Anderson (2000)
Wolman disease successfully treated by bone marrow transplantationBone Marrow Transplantation, 26
RA Anderson, GN Sando (1991)
Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolaseJ Biol Chem, 266
S. Jones, V. Valayannopoulos, E. Schneider, S. Eckert, M. Banikazemi, M. Bialer, S. Cederbaum, A. Chan, A. Dhawan, M. Rocco, J. Domm, G. Enns, D. Finegold, J. Gargus, O. Guardamagna, C. Hendriksz, I. Mahmoud, J. Raiman, L. Selim, C. Whitley, O. Zaki, A. Quinn (2015)
Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infantsGenetics in Medicine, 18
R. Himes, S. Barlow, K. Bove, Norma Quintanilla, R. Sheridan, Rohit Kohli (2016)
Lysosomal Acid Lipase Deficiency Unmasked in Two Children With Nonalcoholic Fatty Liver DiseasePediatrics, 138
H Du, TL Cameron, SJ Garger, GP Pogue, LA Hamm, E White, KM Hanley, GA Grabowski (2008)
Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in miceJ Lipid Res, 49
S. Saito, K. Ohno, Toshihiro Suzuki, H. Sakuraba (2012)
Structural bases of Wolman disease and cholesteryl ester storage disease.Molecular genetics and metabolism, 105 2
JD Horton, JC Cohen, HH Hobbs (2009)
PCSK9: a convertase that coordinates LDL catabolismJ Lipid Res, 50
AD Klein (2013)
Futerman AH Lysosomal storage disorders: old diseases present and future challengesPed Endocrinol Rev, 11
C. Johnston (2011)
Introduction: Why Beat a Tired Horse?Pediatrics, 128
W. Krivit, D. Freese, K. Chan, R. Kulkarni (1992)
Wolman's disease: a review of treatment with bone marrow transplantation and considerations for the future.Bone marrow transplantation, 10 Suppl 1
Rae-Ellen Kavey, D. Simons-Morton, Janet Jesus (2011)
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary ReportPediatrics, 128
H. Chatrath, S. Keilin, B. Attar (2008)
Cholesterol Ester Storage Disease (CESD) Diagnosed in an Asymptomatic AdultDigestive Diseases and Sciences, 54
DS Pratt, MM Kaplan (2000)
Evaluation of abnormal liver-enzyme results in asymptomatic patientsNEJM, 342
(2001)
Executive summary of the third report of the national cholesterol education program (NCEP)JAMA, 285
John Hamilton, I. Jones, R. Srivastava, P. Galloway (2012)
A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2.Clinica chimica acta; international journal of clinical chemistry, 413 15-16
H. Du, M. Levine, C. Ganesa, D. Witte, E. Cole, G. Grabowski (2005)
The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.American journal of human genetics, 77 6
S. Sheriff, H. Du, G. Grabowski (1995)
Characterization of Lysosomal Acid Lipase by Site-directed Mutagenesis and Heterologous Expression (*)The Journal of Biological Chemistry, 270
M. Brown, M. Sobhani, G. Brunschede, J. Goldstein (1976)
Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts.The Journal of biological chemistry, 251 11
S. Scott, Benny Liu, I. Nazarenko, Suparna Martis, J. Kozlitina, Yao Yang, Charina Ramirez, Y. Kasai, T. Hyatt, I. Peter, R. Desnick (2013)
Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groupsHepatology, 58
H. Du, Duan Ming, D. Witte, G. Grabowski (1998)
Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.Human molecular genetics, 7 9
M. Tarantino, D. Mcnamara, P. Granstrom, R. Ellefson, E. Unger, J. Udall (1991)
Lovastatin therapy for cholesterol ester storage disease in two sisters.The Journal of pediatrics, 118 1
(2005)
Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes.
R. Anderson, G. Sando (1991)
Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases.The Journal of biological chemistry, 266 33
A. Beaudet, G. Ferry, B. Nichols, H. Rosenberg (1977)
Cholesterol ester storage disease: clinical, biochemical, and pathological studies.The Journal of pediatrics, 90 6
D. Goff, D. Lloyd‐Jones, G. Bennett, S. Coady, R. D'Agostino, R. Gibbons, P. Greenland, D. Lackland, D. Levy, C. O’Donnell, Jennifer Robinson, J. Schwartz, Susan Shero, Sidney Smith, P. Sorlie, N. Stone, Peter Wilson, Harmon Jordan, Lev Nevo, Janusz Wnek, Jeffrey Anderson, L. Halperin, Nancy Albert, Biykem Bozkurt, R. Brindis, Lesley Curtis, David DeMets, J. Hochman, Richard Kovacs, E. Ohman, S. Pressler, Frank Sellke, Win-Kuang Shen (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation, 129
D. Goff, D. Lloyd-Jones, G. Bennett, Sean Coady, Ralph D'Agostino, Raymond Gibbons, Philip Greenland, Daniel Lackland, Daniel Levy, Christopher O’Donnell, J. Robinson, J. Schwartz, Susan Shero, Sidney Smith, P. Sorlie, N. Stone, P. Wilson (2014)
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 63 25 Pt B
BK Burton, PB Deegan, GM Enns, O Guardamagna, S Horslen, GK Hovingh, SJ Lobritto, V Malinova, VA McLin, J Raiman, M Rocco, S Santra, R Sharma, J Sykut-Cegielska, CB Whitley, S Eckert, V Valayannopoulos, AG Quinn (2015)
Clinical features of lysosomal acid lipase deficiencyJ Pediatr Gastroenerol Nutr., 61
GA Grabowski, H Du, L Charnas (2012)
The online metabolic and molecular basis of inherited disease
W. Haller, K. Sharif, A. Millar, Rachel Brown, P. McKiernan (2009)
Gallbladder Dysfunction in Cholesterol Ester Storage DiseaseJournal of Pediatric Gastroenterology and Nutrition, 50
E. Kyriakides, B. Paul, J. Balint (1972)
Lipid accumulation and acid lipase deficiency in fibroblasts from a family with Wolman's disease, and their apparent correction in vitro.The Journal of laboratory and clinical medicine, 80 6
W. Taylor, N. Unwin (2009)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National
M. Wolman, V. Sterk, S. Gatt, M. Frenkel (1961)
Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant.Pediatrics, 28
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, OS Descamps, O Wiklund, RA Hegele, FJ Raal, JC Defesche, A Wiegman, RD Santos, GF Watts, KG Parhofer, GK Hovingh, PT Kovanen, C Boileau, M Averna, J Boren, E Bruckert, AL Catapano, JA Kuivenhoven, P Pajukanta, K Ray, AF Stalenhoef, E Stroes, MR Taskinen, A Tybjaerg-Hansen (2013)
Familial hypercholesterolemia is underdiagnosed and untreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEur Heart J, 34
Donna Bernstein, Helena Hülkova, M. Bialer, R. Desnick (2013)
Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.Journal of hepatology, 58 6
W. Nyhan, B. Barshop, A. Al-aqeel (2011)
Wolman disease/cholesteryl ester storage disease
MS Brown, SE Dana, JL Goldstein (1975)
Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoproteinProc Natl Acad Sci USA, 72
J. Horton, J. Goldstein, Michael Brown (2002)
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.The Journal of clinical investigation, 109 9
H. Ginsberg, N. Le, M. Short, R. Ramakrishnan, R. Desnick (1987)
Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.The Journal of clinical investigation, 80 6
Venu Tadiboyina, Dora Liu, B. Miskie, Jian Wang, R. Hegele (2005)
Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage diseaseLipids in Health and Disease, 4
H. Bays, Peter Jones, T. Jacobson, D. Cohen, C. Orringer, S. Kothari, D. Azagury, J. Morton, N. Nguyen, E. Westman, D. Horn, W. Scinta, Craig Primack (2016)
Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: EXECUTIVE SUMMARY.Journal of clinical lipidology, 10 1
U. Seedorf, H. Wiebusch, S. Muntoni, N. Christensen, F. Skovby, V. Nickel, M. Roskos, H. Funke, L. Ose, G. Assmann (1995)
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease.Arteriosclerosis, thrombosis, and vascular biology, 15 6
O. Guardamagna, F. Abello, G. Anfossi, M. Pirro (2011)
Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias.The Journal of pediatrics, 159 2
AG Quinn, A Harvey, M Chen, L Christmann, M Leavitt, W Hu (2010)
SBC-102, a recombinant enzyme replacement therapy corrects key abnormalities due to lysosomal acid lipase deficiency
A. Kale, G. Ferry, E. Hawkins (1995)
End-stage renal disease in a patient with cholesteryl ester storage disease following successful liver transplantation and cyclosporine immunosuppression.Journal of pediatric gastroenterology and nutrition, 20 1
Bingnan Zhang, Anthony Porto (2013)
Cholesteryl Ester Storage Disease: Protean Presentations of Lysosomal Acid Lipase DeficiencyJournal of Pediatric Gastroenterology and Nutrition, 56
S. Dahl, Klaus Harzer, A. Rolfs, Bettina Albrecht, Claus Niederau, Christoph Vogt, Sonja Weely, Johannes Aerts, Gerd Müller, Dieter Häussinger (1999)
Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation.Journal of hepatology, 31 4
M. Cummings, G. Watts (1995)
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease.Clinical chemistry, 41 1
B. Burton, M. Balwani, F. Feillet, I. Barić, T. Burrow, C. Grande, M. Çoker, A. Consuelo-Sánchez, P. Deegan, M. Rocco, G. Enns, R. Erbe, F. Ezgu, C. Ficicioglu, K. Furuya, J. Kane, Christina Laukaitis, E. Mengel, E. Neilan, S. Nightingale, H. Peters, M. Scarpa, K. Schwab,, V. Smolka, V. Valayannopoulos, M. Wood, Z. Goodman, Yijun Yang, S. Eckert, Sandra Rojas-Caro, A. Quinn (2015)
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.The New England journal of medicine, 373 11
A. Rosenbaum, C. Cosner, Christopher Mariani, F. Maxfield, O. Wiest, P. Helquist (2010)
Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics.Journal of medicinal chemistry, 53 14
A Abramov, S Schorr, M Wolman (1956)
Generalized xanthomatosis with calcified adrenalsAmer J Dis Child, 91
Lysosomal acid lipase deficiency (LAL-D) is a rare, life-threatening, autosomal recessive, lysosomal storage disease caused by mutations in the LIPA gene, which encodes for lysosomal acid lipase (LAL). This enzyme is necessary for the hydrolysis of cholesteryl ester and triglyceride in lysosomes. Deficient LAL activity causes accumulation of these lipids in lysosomes and a marked decrease in the cytoplasmic free cholesterol concentration, leading to dysfunctional cholesterol homeostasis. The accumulation of neutral lipid occurs predominantly in liver, spleen, and macrophages throughout the body, and the aberrant cholesterol homeostasis causes a marked dyslipidemia. LAL-D is characterized by accelerated atherosclerotic cardiovascular disease (ASCVD) and hepatic microvesicular or mixed steatosis, leading to inflammation, fibrosis, cirrhosis and liver failure. LAL-D presents as a clinical continuum with two phenotypes: the infantile-onset phenotype, formally referred to as Wolman disease, and the later-onset phenotype, formerly referred to as cholesteryl ester storage disease. Infants with LAL-D present within the first few weeks of life with vomiting, diarrhea, hepatosplenomegaly, failure to thrive and rapid progression to liver failure and death by 6–12 months of age. Children and young adults with LAL-D generally present with marked dyslipidemia, hepatic enzyme elevation, hepatomegaly and mixed steatosis by liver biopsy. The average age of the initial signs and symptoms of the later-onset phenotype is about 5 years old. The typical dyslipidemia is a significantly elevated low-density lipoprotein cholesterol (LDL-C) concentration and a low high-density lipoprotein cholesterol (HDL-C) concentration, placing these individuals at heightened risk for premature ASCVD. Diagnosis of the later-onset phenotype of LAL-D requires a heightened awareness of the disease because the dyslipidemia and hepatic transaminase elevation combination are common and overlap with other metabolic disorders. LAL-D should be considered in the differential diagnosis of healthy weight children and young adults with unexplained hepatic transaminase elevation accompanied by an elevated LDL-C level (>160 mg/dL) and low HDL-C level (<35 mg/dL) that is not caused by monogenic and polygenic lipid disorders or secondary factors. Treatment of LAL-D with sebelipase alfa (LAL replacement enzyme) should be considered as the standard of treatment in all individuals diagnosed with LAL-D. Other ASCVD risk factors that may be present (hypertension, tobacco use, diabetes mellitus, etc.) should be managed appropriately, consistent with secondary prevention goals.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Feb 14, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.